Statman, Harris & Eyrich, LLC Announces Class Action Against Humana, Inc. for Violation of Federal Securities Laws -- HUM


CINCINNATI, April 9, 2008 (PRIME NEWSWIRE) -- The Cincinnati class action law firm of Statman, Harris & Eyrich, LLC announces that it has filed a class action lawsuit in the United States District Court for the Western District of Kentucky against Humana, Inc. ("Humana") (NYSE:HUM) on behalf of all persons who purchased shares of Humana common stock between February 4, 2008 and March 11, 2008, inclusive (the "Class Period").

The Complaint alleges that Humana and certain of its officers and directors ("Defendants") violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 by failing to disclose adverse facts regarding the operation Humana's business and its financial performance. The Complaint further alleges that Defendants issued materially false and misleading statements regarding Humana's operations, financial viability, and performance. As a result of these materially false and misleading statements and omissions, Plaintiffs allege that the price of Humana common stock was artificially inflated during the Class Period.

On March 12, 2008, Humana announced that it was revising its earnings estimates because, among others, it was incurring increased costs regarding its prescription drug plans. Following the announcement, shares of Humana fell $6.50 per share, or approximately 13.7%.

If you purchased shares of Humana common stock during the Class Period, you may, no later than May 26, 2008, move the Court to appoint you lead plaintiff of the class. If you have any questions, or would like to discuss your rights, please contact Jeffrey P. Harris, Esq. at (513) 621-2666 or (888) 876-7881, or via e-mail at jharris@statmanharris.com, without any obligation or cost to you.

Statman, Harris & Eyrich, LLC has offices in Chicago, Illinois; Cincinnati, Ohio; and Dayton, Ohio. www.statmanharris.com

More information on this and other class actions can be found on the Class Action Newsline at www.primenewswire.com/ca.



            

Contact Data